The FDA PMA for JenaValve's Trilogy device for TAVR-AR comes months after a court struck down Edwards Lifesciences attempt to ...

Thoracic aortic dissection is often approached as an acute and localised event, and pathological examination has traditionally focused on the dissected segment. In daily practice, however, most ...

A study identified a turning point at which that acceleration typically occurs: around age 50. After this time, the ...

A research team in Xinjiang Uygur Autonomous Region in northwest China has developed a novel diagnostic technique that ...

TAVR, a minimally invasive alternative to open‑heart surgery for severe aortic stenosis, has become the global standard for elderly and high‑risk patients.

A study of more than 20,000 Californians shows that outcomes are better when echo is done at the recommended intervals.

Gary LeGros and Paul Toups returned to Our Lady of Lourdes in Lafayette to thank doctors who performed TAVR and bypass surgeries that saved their lives.

Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...

Genentech has elected to stop a phase 2 trial of a RIPK1 inhibitor early and dump the asset after an analysis revealed the candidate was unlikely to meet the study’s primary endpoint. | Genentech has ...

Turco, an interventional cardiologist, has held roles including CEO of JC Medical and chief medical officer of Medtronic’s aortic and peripheral vascular business.

New concepts in device therapy for advanced heart failure presented in early reports ...

After two decades, JPMorgan Chase’s CEO says he has three or four more years on the job—or maybe more. But even he’s talking about what comes next.